
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.520 | 1.520 | 0.000 |
Stocks | 98.480 | 98.480 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.399 | 20.409 |
Price to Book | 3.827 | 4.040 |
Price to Sales | 1.664 | 2.449 |
Price to Cash Flow | 16.420 | 16.330 |
Dividend Yield | 1.624 | 1.369 |
5 Years Earnings Growth | 10.687 | 12.019 |
Number of long holdings: 53
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 6.45 | 425.7 | -2.34% | |
Eli Lilly | US5324571083 | 6.16 | 757.18 | +0.38% | |
J&J | US4781601046 | 6.13 | 153.64 | -0.47% | |
AstraZeneca | GB0009895292 | 6.10 | 10,280.0 | -0.39% | |
Roche Holding Participation | CH0012032048 | 5.56 | 255.40 | +1.47% | |
Thermo Fisher Scientific | US8835561023 | 3.89 | 441.02 | -1.85% | |
Lonza Group | CH0013841017 | 3.72 | 540.60 | +1.65% | |
UnitedHealth | US91324P1021 | 3.59 | 583.59 | -0.59% | |
Pfizer | US7170811035 | 2.94 | 22.45 | +1.47% | |
AbbVie | US00287Y1091 | 2.71 | 176.79 | -0.38% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNB Global indeks NOK | 106.75B | -9.11 | 14.38 | 12.31 | ||
DNB Teknologi NOK | 68.14B | 40.12 | 21.87 | 22.47 | ||
Pensjonsprofil 80 | 48.17B | -1.11 | 6.91 | 8.11 | ||
DNB Global IV | 38.99B | 28.37 | 16.18 | 14.68 | ||
Pensjonsprofil 50 | 27.45B | -0.08 | 5.48 | 6.14 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review